Sphingolipid regulators of cellular dysfunction in Type 2 diabetes mellitus: a systems overview

Area of Science:

• Biochemistry
• Metabolic Diseases
• Cellular Biology

Background:

• Obesity is a global health crisis, driving metabolic syndrome and Type 2 diabetes mellitus (T2DM).
• Sphingolipids, critical structural and signaling lipids, are increasingly recognized for their roles in insulin resistance and T2DM pathogenesis.
• Lipotoxicity and other T2DM pathological mechanisms involve sphingolipids, though precise cellular pathways remain under investigation.

Purpose of the Study:

• To review current understanding of sphingolipid metabolism and signaling in T2DM.
• To identify key organs and tissues impacted by sphingolipid dysregulation in T2DM.
• To highlight areas requiring future research in sphingolipid-related T2DM pathogenesis.

Main Methods:

• Literature review of current research on sphingolipids and T2DM.
• Analysis of sphingolipid metabolism and signaling pathways.
• Examination of sphingolipid roles in affected organs: pancreas, adipose tissue, skeletal muscle, cardiovascular system, and liver.

Main Results:

• Sphingolipids play integral roles in the development of insulin resistance and T2DM.
• Dysregulated sphingolipid metabolism contributes to lipotoxicity and other T2DM pathologies.
• Specific mechanisms of sphingolipid involvement in T2DM pathogenesis require further elucidation.

Conclusions:

• Sphingolipid metabolism and signaling are critical factors in T2DM.
• Understanding sphingolipid roles in key tissues offers therapeutic targets for T2DM.
• Further investigation into cellular mechanisms is crucial for advancing T2DM treatment strategies.